@Davisite, I'm not sure if this has been asked and I've missed it, but are you able to elaborate on what we should expect from the toxicology studies?
For example, I assume the outcome is not "RC220 passes or (heaven forbid) fails" and therefore can/can't be used in clinical trials. I would also assume that we should expect the studies will show that RC220 is toxic, with the level of toxicity being dependent on the dose given.
But other than a delay, is there anything else that can go wrong with these studies? Is it possible to get a great / good / bad result for RC220 and if so what would those scenarios look like?
Thanks in advance.
- Forums
- General
- General Comments / Chat
@Davisite, I'm not sure if this has been asked and I've missed...
-
- There are more pages in this discussion • 275 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.87 |
Change
-0.155(7.67%) |
Mkt cap ! $317.5M |
Open | High | Low | Value | Volume |
$2.03 | $2.08 | $1.86 | $706.9K | 357.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2637 | $1.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.87 | 577 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2637 | 1.865 |
1 | 10216 | 1.855 |
2 | 5250 | 1.850 |
1 | 971 | 1.845 |
1 | 971 | 1.835 |
Price($) | Vol. | No. |
---|---|---|
1.870 | 577 | 1 |
1.880 | 355 | 1 |
1.900 | 2000 | 1 |
1.930 | 971 | 1 |
1.935 | 284 | 1 |
Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online